NCT02477488View on ClinicalTrials.gov

Optimal Administration of Allopurinol in Dialysis Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
GoutRenal Insufficiency
Interventions
DRUG

Allopurinol

Administration of allopurinol is changed to bedtime (hs) for each patient, at the same dosage as was previously prescribed.

Trial Locations (1)

H1T 2M4

Maisonneuve-Rosemont Hospital, Montreal

All Listed Sponsors
lead

Maisonneuve-Rosemont Hospital

OTHER

NCT02477488 - Optimal Administration of Allopurinol in Dialysis Patients | Biotech Hunter | Biotech Hunter